Cohera Medical

A rapidly growing medical device company actively developing surgical adhesives and sealants.

Learn More

TissuGlu Surgical Adhesive

Eliminate the need for post-surgical drains in most abdominoplasty (tummy tuck) surgeries.

Learn More

Sylys Surgical Sealant

Designed to help reduce anastomotic leakage in gastrointestinal surgical procedures..

Learn More

About Cohera Medical

Cohera Medical, Inc. is a rapidly growing, US based medical device company actively developing surgical adhesives and sealants. TissuGlu Surgical Adhesive, the first synthetic adhesive approved for internal use, is an easily applied biocompatible, resorbable adhesive that requires no mixing or thawing. Indicated for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty, TissuGlu Surgical Adhesive has been shown to eliminate the need for postoperative surgical drains in most abdominoplasty procedures.

Latest News

TissuGlu® Surgical Adhesive helps reduce hospital stays for patients with pressure sores

New study on surgical repair of advanced pressure sores (decubitis ulcer) shows >50% reduction in revision surgery and an 8 day reduction in length of stay RALEIGH, NC, November 29, 2016 - A recent German study published in Journal of Spine (Kuhfuss I, J Spine...
Read More

Cohera Medical, Inc.® Appoints Paul Thomas to its Board of Directors

29 July 2016 Cohera Medical, Inc.,  a leading innovator and developer of absorbable surgical adhesives and sealants, announced today the appointment of Paul Thomas as a member of its Board of Directors. “We are honored to welcome Paul Thomas to our Board of Directors...
Read More

Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.

12 July 2016 Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to begin...
Read More

North Carolina Plastic Surgeon First to Use New Surgical Adhesive Commercially in the U.S.

PITTSBURGH, PA – November 5, 2015 – As part of TissuGlu® Surgical Adhesive’s U.S. commercial launch this week, Cohera Medical, Inc.® is announcing Dr. Joseph Hunstad, board-certified plastic surgeon and co-founder of Hunstad Kortesis Plastic Surgery + MedSpa located...
Read More

Cohera Medical, Inc.® Announces $50 Million in New Financing

PITTSBURGH, PA., October 21, 2015 – Cohera Medical, a leading innovator and developer of absorbable surgical adhesives and sealants, announced closing the first tranche of a $50 million equity financing led by KKR, a leading global investment firm, with participation...
Read More

Cohera Medical Receives CE Marking Approval for Sylys® Surgical Sealant

PITTSBURGH, Pa., August 13, 2015 – Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received CE Marking approval for Sylys® Surgical Sealant, the first synthetic sealant designed...
Read More

Cohera Medical, Inc.® Receives Expedited Access Pathway Designation from FDA for Sylys® Surgical Sealant

PITTSBURGH, June 9, 2015 /PRNewswire/—Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that its Sylys® Surgical Sealant has received Expedited Access Pathway (EAP) designation and priority...
Read More

Cohera Medical, Inc.® Receives FDA Approval of First Tissue Adhesive For Internal Use in the U.S.

Cohera Medical, Inc.®, a leading innovator and developer of surgical adhesives and sealants, announced today that the U.S. Food and Drug Administration (FDA) has approved its TissuGlu® Surgical Adhesive. The approval allows the Company to begin commercial distribution...
Read More

Cohera Medical, Inc.® Enters Agreement with B. Braun Surgical, S.A. for Distribution of TissuGlu® Surgical Adhesive in Select European Countries

Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has entered into an exclusive sales and marketing distribution agreement with B. Braun for its TissuGlu® Surgical Adhesive in Germany, Spain...
Read More

Cohera Medical, Inc.® Receives PMA Approvable Letter from U.S. FDA for TissuGlu® Surgical Adhesive

Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received a letter from the U.S. Food and Drug Administration (FDA) that the pending Premarket Approval Application (PMA) for its...
Read More

Get Updates

Join our mailing list to be among the first to receive updates about new product developments and other news from Cohera Medical.

Sign Up Now

Cohera Medical Corporate Headquarters

227 Fayetteville Street
Suite 900
Raleigh, NC 27601, USA
Phone: 1-800-641-7458
Email – cs@coheramed.com

Cohera Medical, Inc.

c/o HealthLink Europe
De Tweeling 20-22
‘s-Hertogenbosch 5215 MC
The Netherlands

Tel: +31-(0)73-3030500
Fax: +31-(0)13-5479301
Email: cs@healthlinkeurope.com

MKT-0004-EN REV F